Steven Romick - First Pacific Advisors,
Period: Q1 2026
Portfolio date: 31 Mar 2026
No. of stocks: 83
Portfolio value: $6,998,758,247
Holding/activity history for Theravance Biopharma Inc (TBPH)
| Period |
Shares |
% of Portfolio |
Activity |
% Change to Portfolio |
Reported Price |
Value |
Filing |
| 2022 Q3 |
0 |
0.00 |
Sell 100.00%
|
0.02 |
|
|
SEC |
| 2022 Q2 |
176,539 |
0.02 |
Add 26.30%
|
<0.01 |
$9.06 |
$1,599,000 |
SEC |
| 2022 Q1 |
139,774 |
0.02 |
Buy
|
0.02 |
$9.56 |
$1,336,000 |
SEC |